Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development
Heparan sulphate 2-O-sulphotransferase (Hs2st) acts at an intermediate stage in the pathway of biosynthesis of heparan sulphate (HS), catalysing the transfer of sulphate from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the C2-position of selected hexuronic acid residues within the matu...
Gespeichert in:
Veröffentlicht in: | Glycoconjugate journal 2002-05, Vol.19 (4-5), p.347-354 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 354 |
---|---|
container_issue | 4-5 |
container_start_page | 347 |
container_title | Glycoconjugate journal |
container_volume | 19 |
creator | Wilson, Valerie A Gallagher, John T Merry, Catherine L R |
description | Heparan sulphate 2-O-sulphotransferase (Hs2st) acts at an intermediate stage in the pathway of biosynthesis of heparan sulphate (HS), catalysing the transfer of sulphate from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the C2-position of selected hexuronic acid residues within the maturing HS chain. It is well established that 2-O-sulphation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high-affinity ligand-binding interactions. HS plays a central role in embryonic development and cellular function, modulating the activities of an extensive range of growth factors. Interestingly, in contrast to the early failure of embryos entirely lacking HS, Hs2st(-/-) mice survive until birth, but die perinatally due to a complete failure of kidney formation. The phenotype of Hs2st(-/-) mutant kidneys suggests that signalling between two tissues, ureteric bud and metanephric mesenchyme, is disrupted. We discuss candidate signalling molecules that may mediate this interaction. The HS generated by these mice lacks 2-O-sulphate groups but is extensively modified above wild type levels by O-sulphation at C-6 of glucosamine-N-sulfate (GlcNS) residues. We will discuss the potentially altered role of this atypical HS in growth factor signalling. |
doi_str_mv | 10.1023/A:1025325222530 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_758451415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2163996731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-ac479587342415474ccb83ae2d89021c25cd4c85030979b32f8fc87ba081efc03</originalsourceid><addsrcrecordid>eNpVkM1LAzEUxIMotlbP3mTxpIfYl5ekyXqrRV2h0Iuel2w2AUv3w2RX8L83pQXxNI_hN_NgCLlm8MAA-Xz5mERylIhJ4IRMmVScilwvTskUUCMF0DAhFzFuAUAJ1OdkwjBXcsHklDwVrjfBtFkcd94MLkO6ofu7G5IbvQsmuuyuiBiH-8y0ddZ0Y3Jq9-12Xd-4drgkZ97sors66ox8vDy_rwq63ry-rZZrajnCQI0VKpdacYGCSaGEtZXmxmGtc0BmUdpaWC2BQ67yiqPX3mpVGdDMeQt8Rm4PvX3ovkYXh3LbjaFNL0sltZAs1SZofoBs6GIMzpd9-GxM-CkZlPvJymX5b7KUuDnWjlXj6j_-uBH_BeKGZAk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>758451415</pqid></control><display><type>article</type><title>Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wilson, Valerie A ; Gallagher, John T ; Merry, Catherine L R</creator><creatorcontrib>Wilson, Valerie A ; Gallagher, John T ; Merry, Catherine L R</creatorcontrib><description>Heparan sulphate 2-O-sulphotransferase (Hs2st) acts at an intermediate stage in the pathway of biosynthesis of heparan sulphate (HS), catalysing the transfer of sulphate from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the C2-position of selected hexuronic acid residues within the maturing HS chain. It is well established that 2-O-sulphation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high-affinity ligand-binding interactions. HS plays a central role in embryonic development and cellular function, modulating the activities of an extensive range of growth factors. Interestingly, in contrast to the early failure of embryos entirely lacking HS, Hs2st(-/-) mice survive until birth, but die perinatally due to a complete failure of kidney formation. The phenotype of Hs2st(-/-) mutant kidneys suggests that signalling between two tissues, ureteric bud and metanephric mesenchyme, is disrupted. We discuss candidate signalling molecules that may mediate this interaction. The HS generated by these mice lacks 2-O-sulphate groups but is extensively modified above wild type levels by O-sulphation at C-6 of glucosamine-N-sulfate (GlcNS) residues. We will discuss the potentially altered role of this atypical HS in growth factor signalling.</description><identifier>ISSN: 0282-0080</identifier><identifier>EISSN: 1573-4986</identifier><identifier>DOI: 10.1023/A:1025325222530</identifier><identifier>PMID: 12975615</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Animals ; Embryonic and Fetal Development - genetics ; Embryonic and Fetal Development - physiology ; Fibroblast Growth Factor 1 - pharmacology ; Fibroblast Growth Factor 2 - pharmacology ; Heparan sulfate ; Heparitin Sulfate - biosynthesis ; Heparitin Sulfate - chemistry ; Kidney - embryology ; Kidney - enzymology ; Ligands ; Mice ; Mice, Knockout ; Models, Biological ; Mutagenesis, Insertional ; Phenotype ; Signal Transduction ; Sulfotransferases - deficiency ; Sulfotransferases - genetics ; Sulfotransferases - physiology</subject><ispartof>Glycoconjugate journal, 2002-05, Vol.19 (4-5), p.347-354</ispartof><rights>Kluwer Academic Publishers 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c320t-ac479587342415474ccb83ae2d89021c25cd4c85030979b32f8fc87ba081efc03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12975615$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, Valerie A</creatorcontrib><creatorcontrib>Gallagher, John T</creatorcontrib><creatorcontrib>Merry, Catherine L R</creatorcontrib><title>Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development</title><title>Glycoconjugate journal</title><addtitle>Glycoconj J</addtitle><description>Heparan sulphate 2-O-sulphotransferase (Hs2st) acts at an intermediate stage in the pathway of biosynthesis of heparan sulphate (HS), catalysing the transfer of sulphate from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the C2-position of selected hexuronic acid residues within the maturing HS chain. It is well established that 2-O-sulphation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high-affinity ligand-binding interactions. HS plays a central role in embryonic development and cellular function, modulating the activities of an extensive range of growth factors. Interestingly, in contrast to the early failure of embryos entirely lacking HS, Hs2st(-/-) mice survive until birth, but die perinatally due to a complete failure of kidney formation. The phenotype of Hs2st(-/-) mutant kidneys suggests that signalling between two tissues, ureteric bud and metanephric mesenchyme, is disrupted. We discuss candidate signalling molecules that may mediate this interaction. The HS generated by these mice lacks 2-O-sulphate groups but is extensively modified above wild type levels by O-sulphation at C-6 of glucosamine-N-sulfate (GlcNS) residues. We will discuss the potentially altered role of this atypical HS in growth factor signalling.</description><subject>Animals</subject><subject>Embryonic and Fetal Development - genetics</subject><subject>Embryonic and Fetal Development - physiology</subject><subject>Fibroblast Growth Factor 1 - pharmacology</subject><subject>Fibroblast Growth Factor 2 - pharmacology</subject><subject>Heparan sulfate</subject><subject>Heparitin Sulfate - biosynthesis</subject><subject>Heparitin Sulfate - chemistry</subject><subject>Kidney - embryology</subject><subject>Kidney - enzymology</subject><subject>Ligands</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Models, Biological</subject><subject>Mutagenesis, Insertional</subject><subject>Phenotype</subject><subject>Signal Transduction</subject><subject>Sulfotransferases - deficiency</subject><subject>Sulfotransferases - genetics</subject><subject>Sulfotransferases - physiology</subject><issn>0282-0080</issn><issn>1573-4986</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpVkM1LAzEUxIMotlbP3mTxpIfYl5ekyXqrRV2h0Iuel2w2AUv3w2RX8L83pQXxNI_hN_NgCLlm8MAA-Xz5mERylIhJ4IRMmVScilwvTskUUCMF0DAhFzFuAUAJ1OdkwjBXcsHklDwVrjfBtFkcd94MLkO6ofu7G5IbvQsmuuyuiBiH-8y0ddZ0Y3Jq9-12Xd-4drgkZ97sors66ox8vDy_rwq63ry-rZZrajnCQI0VKpdacYGCSaGEtZXmxmGtc0BmUdpaWC2BQ67yiqPX3mpVGdDMeQt8Rm4PvX3ovkYXh3LbjaFNL0sltZAs1SZofoBs6GIMzpd9-GxM-CkZlPvJymX5b7KUuDnWjlXj6j_-uBH_BeKGZAk</recordid><startdate>200205</startdate><enddate>200205</enddate><creator>Wilson, Valerie A</creator><creator>Gallagher, John T</creator><creator>Merry, Catherine L R</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>200205</creationdate><title>Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development</title><author>Wilson, Valerie A ; Gallagher, John T ; Merry, Catherine L R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-ac479587342415474ccb83ae2d89021c25cd4c85030979b32f8fc87ba081efc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Embryonic and Fetal Development - genetics</topic><topic>Embryonic and Fetal Development - physiology</topic><topic>Fibroblast Growth Factor 1 - pharmacology</topic><topic>Fibroblast Growth Factor 2 - pharmacology</topic><topic>Heparan sulfate</topic><topic>Heparitin Sulfate - biosynthesis</topic><topic>Heparitin Sulfate - chemistry</topic><topic>Kidney - embryology</topic><topic>Kidney - enzymology</topic><topic>Ligands</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Models, Biological</topic><topic>Mutagenesis, Insertional</topic><topic>Phenotype</topic><topic>Signal Transduction</topic><topic>Sulfotransferases - deficiency</topic><topic>Sulfotransferases - genetics</topic><topic>Sulfotransferases - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, Valerie A</creatorcontrib><creatorcontrib>Gallagher, John T</creatorcontrib><creatorcontrib>Merry, Catherine L R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Glycoconjugate journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, Valerie A</au><au>Gallagher, John T</au><au>Merry, Catherine L R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development</atitle><jtitle>Glycoconjugate journal</jtitle><addtitle>Glycoconj J</addtitle><date>2002-05</date><risdate>2002</risdate><volume>19</volume><issue>4-5</issue><spage>347</spage><epage>354</epage><pages>347-354</pages><issn>0282-0080</issn><eissn>1573-4986</eissn><abstract>Heparan sulphate 2-O-sulphotransferase (Hs2st) acts at an intermediate stage in the pathway of biosynthesis of heparan sulphate (HS), catalysing the transfer of sulphate from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the C2-position of selected hexuronic acid residues within the maturing HS chain. It is well established that 2-O-sulphation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high-affinity ligand-binding interactions. HS plays a central role in embryonic development and cellular function, modulating the activities of an extensive range of growth factors. Interestingly, in contrast to the early failure of embryos entirely lacking HS, Hs2st(-/-) mice survive until birth, but die perinatally due to a complete failure of kidney formation. The phenotype of Hs2st(-/-) mutant kidneys suggests that signalling between two tissues, ureteric bud and metanephric mesenchyme, is disrupted. We discuss candidate signalling molecules that may mediate this interaction. The HS generated by these mice lacks 2-O-sulphate groups but is extensively modified above wild type levels by O-sulphation at C-6 of glucosamine-N-sulfate (GlcNS) residues. We will discuss the potentially altered role of this atypical HS in growth factor signalling.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>12975615</pmid><doi>10.1023/A:1025325222530</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0282-0080 |
ispartof | Glycoconjugate journal, 2002-05, Vol.19 (4-5), p.347-354 |
issn | 0282-0080 1573-4986 |
language | eng |
recordid | cdi_proquest_journals_758451415 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Embryonic and Fetal Development - genetics Embryonic and Fetal Development - physiology Fibroblast Growth Factor 1 - pharmacology Fibroblast Growth Factor 2 - pharmacology Heparan sulfate Heparitin Sulfate - biosynthesis Heparitin Sulfate - chemistry Kidney - embryology Kidney - enzymology Ligands Mice Mice, Knockout Models, Biological Mutagenesis, Insertional Phenotype Signal Transduction Sulfotransferases - deficiency Sulfotransferases - genetics Sulfotransferases - physiology |
title | Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heparan%20sulfate%202-O-sulfotransferase%20(Hs2st)%20and%20mouse%20development&rft.jtitle=Glycoconjugate%20journal&rft.au=Wilson,%20Valerie%20A&rft.date=2002-05&rft.volume=19&rft.issue=4-5&rft.spage=347&rft.epage=354&rft.pages=347-354&rft.issn=0282-0080&rft.eissn=1573-4986&rft_id=info:doi/10.1023/A:1025325222530&rft_dat=%3Cproquest_cross%3E2163996731%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=758451415&rft_id=info:pmid/12975615&rfr_iscdi=true |